Cargando…

Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh

The longevity of immune responses induced by different degrees of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection provides information important to understanding protection against coronavirus disease 2019 (COVID-19). Here, we report the persistence of SARS-CoV-2 spike recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhtar, Marjahan, Basher, Salima Raiyan, Nizam, Nuder Nower, Kamruzzaman, Mohammad, Khaton, Fatema, Banna, Hasan Al, Kaisar, M Hasanul, Karmakar, Polash Chandra, Hakim, Al, Akter, Afroza, Ahmed, Tasnuva, Tauheed, Imam, Islam, Shaumik, Ahmmed, Faisal, Mahamud, Shakil, Hasnat, Mohammad Abul, Sumon, Mostafa Aziz, Rashed, Asif, Ghosh, Shuvro, Calderwood, Stephen B., Harris, Jason B., Charles, Richelle C., LaRocque, Regina C., Ryan, Edward T., Banu, Sayera, Shirin, Tahmina, Chowdhury, Fahima, Bhuiyan, Taufiqur Rahman, Qadri, Firdausi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791541/
https://www.ncbi.nlm.nih.gov/pubmed/36578502
http://dx.doi.org/10.3389/fimmu.2022.1052374
_version_ 1784859428461215744
author Akhtar, Marjahan
Basher, Salima Raiyan
Nizam, Nuder Nower
Kamruzzaman, Mohammad
Khaton, Fatema
Banna, Hasan Al
Kaisar, M Hasanul
Karmakar, Polash Chandra
Hakim, Al
Akter, Afroza
Ahmed, Tasnuva
Tauheed, Imam
Islam, Shaumik
Ahmmed, Faisal
Mahamud, Shakil
Hasnat, Mohammad Abul
Sumon, Mostafa Aziz
Rashed, Asif
Ghosh, Shuvro
Calderwood, Stephen B.
Harris, Jason B.
Charles, Richelle C.
LaRocque, Regina C.
Ryan, Edward T.
Banu, Sayera
Shirin, Tahmina
Chowdhury, Fahima
Bhuiyan, Taufiqur Rahman
Qadri, Firdausi
author_facet Akhtar, Marjahan
Basher, Salima Raiyan
Nizam, Nuder Nower
Kamruzzaman, Mohammad
Khaton, Fatema
Banna, Hasan Al
Kaisar, M Hasanul
Karmakar, Polash Chandra
Hakim, Al
Akter, Afroza
Ahmed, Tasnuva
Tauheed, Imam
Islam, Shaumik
Ahmmed, Faisal
Mahamud, Shakil
Hasnat, Mohammad Abul
Sumon, Mostafa Aziz
Rashed, Asif
Ghosh, Shuvro
Calderwood, Stephen B.
Harris, Jason B.
Charles, Richelle C.
LaRocque, Regina C.
Ryan, Edward T.
Banu, Sayera
Shirin, Tahmina
Chowdhury, Fahima
Bhuiyan, Taufiqur Rahman
Qadri, Firdausi
author_sort Akhtar, Marjahan
collection PubMed
description The longevity of immune responses induced by different degrees of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection provides information important to understanding protection against coronavirus disease 2019 (COVID-19). Here, we report the persistence of SARS-CoV-2 spike receptor-binding domain (RBD) specific antibodies and memory B cells recognizing this antigen in sequential samples from patients in Bangladesh with asymptomatic, mild, moderate and severe COVID-19 out to six months following infection. Since the development of long-lived memory B cells, as well as antibody production, is likely to be dependent on T helper (Th) cells, we also investigated the phenotypic changes of Th cells in COVID-19 patients over time following infection. Our results show that patients with moderate to severe COVID-19 mounted significant levels of IgG antibodies out to six months following infection, while patients with asymptomatic or mild disease had significant levels of IgG antibodies out to 3 months following infection, but these then fell more rapidly at 6 months than in patients with higher disease severity. Patients from all severity groups developed circulating memory B cells (MBCs) specific to SARS-CoV-2 spike RBD by 3 months following infection, and these persisted until the last timepoint measured at 6 months. A T helper cell response with an effector memory phenotype was observed following infection in all symptomatic patients, while patients with asymptomatic infection had no significant increases in effector Th1, Th2 and Th17 effector memory cell responses. Our results suggest that the strength and magnitude of antibody and memory B cells induced following SARS-CoV-2 infection depend on the severity of the disease. Polarization of the Th cell response, with an increase in Th effector memory cells, occurs in symptomatic patients by day 7 following infection, with increases seen in Th1, Th2, Th17 and follicular helper T cell subsets.
format Online
Article
Text
id pubmed-9791541
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97915412022-12-27 Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh Akhtar, Marjahan Basher, Salima Raiyan Nizam, Nuder Nower Kamruzzaman, Mohammad Khaton, Fatema Banna, Hasan Al Kaisar, M Hasanul Karmakar, Polash Chandra Hakim, Al Akter, Afroza Ahmed, Tasnuva Tauheed, Imam Islam, Shaumik Ahmmed, Faisal Mahamud, Shakil Hasnat, Mohammad Abul Sumon, Mostafa Aziz Rashed, Asif Ghosh, Shuvro Calderwood, Stephen B. Harris, Jason B. Charles, Richelle C. LaRocque, Regina C. Ryan, Edward T. Banu, Sayera Shirin, Tahmina Chowdhury, Fahima Bhuiyan, Taufiqur Rahman Qadri, Firdausi Front Immunol Immunology The longevity of immune responses induced by different degrees of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection provides information important to understanding protection against coronavirus disease 2019 (COVID-19). Here, we report the persistence of SARS-CoV-2 spike receptor-binding domain (RBD) specific antibodies and memory B cells recognizing this antigen in sequential samples from patients in Bangladesh with asymptomatic, mild, moderate and severe COVID-19 out to six months following infection. Since the development of long-lived memory B cells, as well as antibody production, is likely to be dependent on T helper (Th) cells, we also investigated the phenotypic changes of Th cells in COVID-19 patients over time following infection. Our results show that patients with moderate to severe COVID-19 mounted significant levels of IgG antibodies out to six months following infection, while patients with asymptomatic or mild disease had significant levels of IgG antibodies out to 3 months following infection, but these then fell more rapidly at 6 months than in patients with higher disease severity. Patients from all severity groups developed circulating memory B cells (MBCs) specific to SARS-CoV-2 spike RBD by 3 months following infection, and these persisted until the last timepoint measured at 6 months. A T helper cell response with an effector memory phenotype was observed following infection in all symptomatic patients, while patients with asymptomatic infection had no significant increases in effector Th1, Th2 and Th17 effector memory cell responses. Our results suggest that the strength and magnitude of antibody and memory B cells induced following SARS-CoV-2 infection depend on the severity of the disease. Polarization of the Th cell response, with an increase in Th effector memory cells, occurs in symptomatic patients by day 7 following infection, with increases seen in Th1, Th2, Th17 and follicular helper T cell subsets. Frontiers Media S.A. 2022-12-12 /pmc/articles/PMC9791541/ /pubmed/36578502 http://dx.doi.org/10.3389/fimmu.2022.1052374 Text en Copyright © 2022 Akhtar, Basher, Nizam, Kamruzzaman, Khaton, Banna, Kaisar, Karmakar, Hakim, Akter, Ahmed, Tauheed, Islam, Ahmmed, Mahamud, Hasnat, Sumon, Rashed, Ghosh, Calderwood, Harris, Charles, LaRocque, Ryan, Banu, Shirin, Chowdhury, Bhuiyan and Qadri https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Akhtar, Marjahan
Basher, Salima Raiyan
Nizam, Nuder Nower
Kamruzzaman, Mohammad
Khaton, Fatema
Banna, Hasan Al
Kaisar, M Hasanul
Karmakar, Polash Chandra
Hakim, Al
Akter, Afroza
Ahmed, Tasnuva
Tauheed, Imam
Islam, Shaumik
Ahmmed, Faisal
Mahamud, Shakil
Hasnat, Mohammad Abul
Sumon, Mostafa Aziz
Rashed, Asif
Ghosh, Shuvro
Calderwood, Stephen B.
Harris, Jason B.
Charles, Richelle C.
LaRocque, Regina C.
Ryan, Edward T.
Banu, Sayera
Shirin, Tahmina
Chowdhury, Fahima
Bhuiyan, Taufiqur Rahman
Qadri, Firdausi
Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh
title Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh
title_full Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh
title_fullStr Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh
title_full_unstemmed Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh
title_short Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh
title_sort longevity of memory b cells and antibodies, as well as the polarization of effector memory helper t cells, are associated with disease severity in patients with covid-19 in bangladesh
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791541/
https://www.ncbi.nlm.nih.gov/pubmed/36578502
http://dx.doi.org/10.3389/fimmu.2022.1052374
work_keys_str_mv AT akhtarmarjahan longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT bashersalimaraiyan longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT nizamnudernower longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT kamruzzamanmohammad longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT khatonfatema longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT bannahasanal longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT kaisarmhasanul longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT karmakarpolashchandra longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT hakimal longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT akterafroza longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT ahmedtasnuva longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT tauheedimam longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT islamshaumik longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT ahmmedfaisal longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT mahamudshakil longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT hasnatmohammadabul longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT sumonmostafaaziz longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT rashedasif longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT ghoshshuvro longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT calderwoodstephenb longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT harrisjasonb longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT charlesrichellec longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT larocquereginac longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT ryanedwardt longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT banusayera longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT shirintahmina longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT chowdhuryfahima longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT bhuiyantaufiqurrahman longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh
AT qadrifirdausi longevityofmemorybcellsandantibodiesaswellasthepolarizationofeffectormemoryhelpertcellsareassociatedwithdiseaseseverityinpatientswithcovid19inbangladesh